Loading
Ambry Genetics is a US genetic testing laboratory whose hereditary cancer panels include CancerNext and BRCAplus.
A clinical laboratory in California (CLIA 05D0981414, NIH Genetic Testing Registry laboratory 61756) with hereditary cancer panels registered in GTR: CancerNext (41 genes), CancerNext-Expanded (90 genes), BRCAplus (13 genes), and versions of each with paired RNA analysis (RNAinsight). Each is registered as a test developed by the laboratory.
A blood test from Ambry Genetics for 13 genes linked to inherited breast cancer, including BRCA1, BRCA2, PALB2 and TP53.
Ambry Genetics' multi-gene blood tests for inherited cancer risk: CancerNext covers 41 genes and CancerNext-Expanded 90, ordered through a clinician.
Shares Hereditary cancer syndromes, Germline (hereditary) testing.
Shares Hereditary cancer syndromes, Germline (hereditary) testing.
Shares Hereditary cancer syndromes, Germline (hereditary) testing.
Shares Hereditary cancer syndromes, Germline (hereditary) testing.
Shares Hereditary cancer syndromes, Germline (hereditary) testing.
Shares Hereditary cancer syndromes, Germline (hereditary) testing.
Shares Hereditary cancer syndromes, Germline (hereditary) testing.
Shares Hereditary cancer syndromes, Germline (hereditary) testing.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/